| Vascular Insights LLC
engages in the design, development, manufacture, and
marketing of medical devices for the minimally invasive
treatment of peripheral vascular disease.
The company is focused on treatments based
on mechanically enhanced drug delivery. Its developmental
products include a pharmacomechanical device for delivery
of, for example, a thrombolytic agent, and a vascular
ablation system for treatment of varicose veins. The company
plans to sells its products primarily in the U.S. and
Europe.
The company's therapeutic devices enable
interventional radiologists, vascular surgeons,
phlebologists, and others to treat peripheral vascular
diseases. A vascular treatment device may be used for
ablating blood vessels, such as varicose veins, and for
treating thrombosis by macerating a clot and injecting a
thrombolytic drug, among other uses.
The company has received 510(k) clearance
from the U.S. Food and Drug Administration (FDA) to market
its ClariVein™ infusion catheter for infusion of
physician-specified agents in the peripheral vasculature.
|